Philips today launched a new upgrade program for its Allura Xper family of cardiovascular X-ray devices.
Philips enhances Xper line
Philips today launched a new upgrade program for its Allura Xper family of cardiovascular X-ray devices. The upgrade includes remote diagnostics that allow Philips to automatically monitor each system and send alerts, when issues arise with the onsite Xper systems. In North America, the upgrade will allow customer service teams to take control of systems and guide customers through the required steps to resolve problems. With the upgrade, customers will be able to run other enhancements and applications, including XperGuide, CT-like soft tissue imaging providing live 3D needle image guidance during percutaneous needle interventions in the angio lab; XperSwing,an automated dual-axis rotational angiography option allowing acquisition of multiple anatomical projections in a single run, thereby reducing dose and contrast medium; and FlexVisionXL, which employs a 56-inch LCD screen that displays multiple images simultaneously.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.